Answers are grounded in this paper and cite their sources.
Case report demonstrates CNS relapse in patient with acute promyelocytic leukemia, highlighting the need for prompt intervention.
Acute promyelocytic leukemia (APL) is a unique and highly manageable form of acute myeloid leukemia, typically identified by the presence of the PML-RARA fusion gene. However, relapse in the central nervous system (CNS) continues to be a rare but serious complication, particularly in patients with high-risk genetic features such as FLT3-ITD mutations. CNS involvement significantly complicates the course of APL and demands prompt recognition and management. We present the case of a 60-year-old male diagnosed with FLT3-ITD positive APL who developed CNS relapse. The patient underwent a comprehensive diagnostic workup, involving magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) evaluation using next-generation sequencing and flow cytometry. The patient was treated with intrathecal chemotherapy. MRI revealed mild thickening and enhancement of the leptomeninges, suggestive of leptomeningeal in-volvement. CSF cytology and flow cytometry confirmed the presence of abnormal promyelocytes. The patient received intrathecal chemotherapy, which led to clinical improvement, with a reduction in the severity of headaches. CNS relapse in APL, though rare, requires high clinical suspicion, particularly in patients with FLT3-ITD mutations. Early diagnosis using imaging and CSF analysis, followed by prompt intrathecal therapy, is crucial for effective management. This case highlights the need for vigilance in monitoring high-risk APL patients for CNS complications and emphasizes the importance of early intervention to improve outcomes.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: